Life cycle and pathogenesis of hepatitis D virus: A review

World Journal of Hepatology

Volumn 5, Issue 12, 2013, Pages 666-675

  Abbas, Zaigham ^a   Afzal, Rafia ^a  

^a SINDH INSTITUTE OF UROLOGY AND TRANSPLANTATION   (Pakistan)

Author keywords

Hepatitis B virus; Hepatitis D virus; Hepatitis D virus pathogenicity; Hepatitis delta antigens; Hepatocellular carcinoma; Host pathogen interactions; Interferonalpha; Virus replication

Indexed keywords

EID: 84892900219     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v5.i12.666     Document Type: Article

References (79)

1. Lin JH, Chang MF, Baker SC, Govindarajan S, Lai MM. Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol 1990; 64: 4051-4058 [PMID: 2200884 DOI: 10.1055/s-0032-1323628]
2. Abbas Z, Jafri W, Raza S. Hepatitis D: Scenario in the Asia- Pacific region. World J Gastroenterol 2010; 16: 554-562 [PMID: 20128022 DOI: 10.3748/wjg.v16.i5.554]
3. Wang CJ, Chen PJ, Wu JC, Patel D, Chen DS. Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles. J Virol 1991; 65: 6630-6636 [PMID: 1658366]
4. Lai MM. Molecular biologic and pathogenetic analysis of hepatitis delta virus. J Hepatol 1995; 22: 127-131 [PMID: 7602064]
5. Casaca A, Fardilha M, da Cruz e Silva E, Cunha C. The heterogeneous ribonuclear protein C interacts with the hepatitis delta virus small antigen. Virol J 2011; 8: 358 [PMID: 21774814 DOI: 10.1186/1743-422X-8-358]
6. Gudima S, Chang J, Moraleda G, Azvolinsky A, Taylor J. Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA. J Virol 2002; 76: 3709-3719 [PMID: 11907210 DOI: 10.1128/JVI.76.8.3709-3719.2002]
7. Flores R, Ruiz-Ruiz S, Serra P. Viroids and hepatitis delta virus. Semin Liver Dis 2012; 32: 201-210 [PMID: 22932968 DOI: 10.1055/s-0032-1323624]
8. Dastgerdi ES, Herbers U, Tacke F. Molecular and clinical aspects of hepatitis D virus infections. World J Virol 2012; 1: 71-78 [PMID: 24175212 DOI: 10.5501/wjv.v1.i3.71]
9. Greco-Stewart V, Pelchat M. Interaction of host cellular proteins with components of the hepatitis delta virus. Viruses 2010; 2: 189-212 [PMID: 21994607 DOI: 10.3390/v2010189]
10. Flores R, Grubb D, Elleuch A, Nohales MÁ, Delgado S, Gago S. Rolling-circle replication of viroids, viroid-like satellite RNAs and hepatitis delta virus: variations on a theme. RNA Biol 2011; 8: 200-206 [PMID: 21358283 DOI: 10.4161/ rna.8.2.14238]
11. Huang CR, Lo SJ. Evolution and diversity of the human hepatitis d virus genome. Adv Bioinformatics 2010 Feb 24; Epub ahead of print [PMID: 20204073 DOI: 10.1155/2010/323654]
12. Sikora D, Greco-Stewart VS, Miron P, Pelchat M. The hepatitis delta virus RNA genome interacts with eEF1A1, p54(nrb), hnRNP-L, GAPDH and ASF/SF2. Virology 2009; 390: 71-78 [PMID: 19464723 DOI: 10.1016/j.virol.2009.04.022]
13. Wang JG, Lemon SM. Hepatitis delta virus antigen forms dimers and multimeric complexes in vivo. J Virol 1993; 67: 446-454 [PMID: 7677957]
14. Casey JL. Control of ADAR1 editing of hepatitis delta virus RNAs. Curr Top Microbiol Immunol 2012; 353: 123-143 [PMID: 21732238 DOI: 10.1007/82_2011_146]
15. Sato S, Cornillez-Ty C, Lazinski DW. By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression. J Virol 2004; 78: 8120-8134 [PMID: 15254184 DOI: 10.1128/JVI.78.15.8120-813 4.2004]
16. Tseng CH, Lai MM. Hepatitis delta virus RNA replication. Viruses 2009; 1: 818-831 [PMID: 21994571 DOI: 10.3390/ v1030818]
17. Wang YC, Huang CR, Chao M, Lo SJ. The C-terminal sequence of the large hepatitis delta antigen is variable but retains the ability to bind clathrin. Virol J 2009; 6: 31 [PMID: 19284884 DOI: 10.1186/1743-422X-6-31]
18. Li YJ, Stallcup MR, Lai MM. Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. J Virol 2004; 78: 13325-13334 [PMID: 15542683 DOI: 10.1128/JVI.78.23.13325- 13334.2004]
19. Choi SH, Park KJ, Hwang SB. Large hepatitis delta antigen is phosphorylated at multiple sites and phosphorylation is associated with protein conformational change. Intervirology 2002; 45: 142-149 [PMID: 12403918 DOI: 10.1159/000065867]
20. Hong SY, Chen PJ. Phosphorylation of serine 177 of the small hepatitis delta antigen regulates viral antigenomic RNA replication by interacting with the processive RNA polymerase II. J Virol 2010; 84: 1430-1438 [PMID: 19923176 DOI: 10.1128/JVI.02083-09]
21. Yeh TS, Lee YH. Assembly of hepatitis delta virus particles: package of multimeric hepatitis delta virus genomic RNA and role of phosphorylation. Virology 1998; 249: 12-20 [PMID: 9740772 DOI: 10.1006/viro.1998.9310]
22. Mu JJ, Tsay YG, Juan LJ, Fu TF, Huang WH, Chen DS, Chen PJ. The small delta antigen of hepatitis delta virus is an acetylated protein and acetylation of lysine 72 may influence its cellular localization and viral RNA synthesis. Virology 2004; 319: 60-70 [PMID: 14967488 DOI: 10.1016/j.virol.2003.10.024]
23. Tseng CH, Cheng TS, Shu CY, Jeng KS, Lai MM. Modification of small hepatitis delta virus antigen by SUMO protein. J Virol 2010; 84: 918-927 [PMID: 19889771 DOI: 10.1128/ JVI.01034-09]
24. Lamas Longarela O, Schmidt TT, Schöneweis K, Romeo R, Wedemeyer H, Urban S, Schulze A. Proteoglycans act as cellular hepatitis delta virus attachment receptors. PLoS One 2013; 8: e58340 [PMID: 23505490 DOI: 10.1371/journal. pone.0058340]
25. Engelke M, Mills K, Seitz S, Simon P, Gripon P, Schnölzer M, Urban S. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology 2006; 43: 750-760 [PMID: 16557545 DOI: 10.1002/hep.21112]
26. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012; 1: e00049 [PMID: 23150796 DOI: 10.7554/eLife.00049]
27. Huang WH, Chen YS, Chen PJ. Nucleolar targeting of hepatitis delta antigen abolishes its ability to initiate viral antigenomic RNA replication. J Virol 2008; 82: 692-699 [PMID: 17989182 DOI: 10.1128/JVI.01155-07]
28. Niro GA, Smedile A. Current concept in the pathophysiol- ogy of hepatitis delta infection. Curr Infect Dis Rep 2012; 14: 9-14 [PMID: 22161240 DOI: 10.1007/s11908-011-0233-5]
29. Govindarajan S, Fields HA, Humphrey CD, Margolis HS. Pathologic and ultrastructural changes of acute and chronic delta hepatitis in an experimentally infected chimpanzee. Am J Pathol 1986; 122: 315-322 [PMID: 3511726]
30. Kamimura T, Ponzetto A, Bonino F, Feinstone SM, Gerin JL, Purcell RH. Cytoplasmic tubular structures in liver of HBsAg carrier chimpanzees infected with delta agent and comparison with cytoplasmic structures in non-A, non-B hepatitis. Hepatology 1983; 3: 631-637 [PMID: 6413349 DOI: 10.1002/hep.1840030502]
31. Canese MG, Rizzetto M, Novara R, London WT, Purcell RH. Experimental infection of chimpanzees with the HBsAgassociated delta (delta) agent: an ultrastructural study. J Med Virol 1984; 13: 63-72 [PMID: 6420512 DOI: 10.1002/ jmv.1890130108]
32. Ponzetto A, Hoyer BH, Popper H, Engle R, Purcell RH, Gerin JL. Titration of the infectivity of hepatitis D virus in chimpanzees. J Infect Dis 1987; 155: 72-78 [PMID: 3794405 DOI: 10.1093/infdis/155.1.72]
33. Cole SM, Gowans EJ, Macnaughton TB, Hall PD, Burrell CJ. Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen. Hepatology 1991; 13: 845-851 [PMID: 1709411 DOI: 10.1002/hep.184013050]
34. Lefkowitch JH, Goldstein H, Yatto R, Gerber MA. Cytopathic liver injury in acute delta virus hepatitis. Gastroenterology 1987; 92: 1262-1266 [PMID: 3557018]
35. Popper H, Thung SN, Gerber MA, Hadler SC, de Monzon M, Ponzetto A, Anzola E, Rivera D, Mondolfi A, Bracho A. Histologic studies of severe delta agent infection in Venezuelan Indians. Hepatology 1983; 3: 906-912 [PMID: 6629319 DOI: 10.1002/hep.1840030603]
36. Casey JL, Gerin JL. The woodchuck model of HDV infection. Curr Top Microbiol Immunol 2006; 307: 211-225 [PMID: 16903228 DOI: 10.1007/3-540-29802-9_11]
37. Casey JL, Tennant BC, Gerin JL. Genetic changes in hepatitis delta virus from acutely and chronically infected woodchucks. J Virol 2006; 80: 6469-6477 [PMID: 16775334 DOI: 10.1128/JVI.00245-06]
38. Fiedler M, Lu M, Siegel F, Whipple J, Roggendorf M. Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine. Vaccine 2001; 19: 4618-4626 [PMID: 11535309 DOI: 10.1016/s0264-410x(01)00245-6]
39. Fiedler M, Roggendorf M. Vaccination against hepatitis delta virus infection: studies in the woodchuck (Marmota monax) model. Intervirology 2001; 44: 154-161 [PMID: 11509876 DOI: 10.1159/000050042]
40. Fiedler M, Roggendorf M. Immunology of HDV infection. Curr Top Microbiol Immunol 2006; 307: 187-209 [PMID: 16903227 DOI: 10.1007/3-540-29802-9_10]
41. D'Ugo E, Canitano A, Catone S, Argentini C, Giuseppetti R, Orobello S, Palmieri G, Rapicetta M. Kinetics of WHV-HDV replication in acute fatal course of woodchuck hepatitis. Arch Virol 2008; 153: 2069-2076 [PMID: 18985276 DOI: 10.1007/ s00705-008-0236-1]
42. Hansson BG, Riesbeck K, Nordenfelt E, Weiland O. Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response. Prog Clin Biol Res 1991; 364: 421-427 [PMID: 1826956]
43. Hourioux C, Sureau C, Poisson F, Brand D, Goudeau A, Roingeard P. Interaction between hepatitis delta virus-encoded proteins and hepatitis B virus envelope protein domains. J Gen Virol 1998; 79 ( Pt 5): 1115-1119 [PMID: 9603326]
44. de Sousa BC, Cunha C. Development of mathematical models for the analysis of hepatitis delta virus viral dynamics. PLoS One 2010; 5: [PMID: 20862328 DOI: 10.1371/journal. pone.0012512]
45. Williams V, Brichler S, Radjef N, Lebon P, Goffard A, Hober D, Fagard R, Kremsdorf D, Dény P, Gordien E. Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. J Gen Virol 2009; 90: 2759-2767 [PMID: 19625466 DOI: 10.1099/ vir.0.011239-0]
46. Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, Ronchi G, Colombo M. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 2009; 136: 1629-1638 [PMID: 19208358 DOI: 10.1053/ j.gastro.2009.01.052]
47. Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 2010; 7: 31-40 [PMID: 20051970 DOI: 10.1038/nrgastro.2009.205]
48. Schaper M, Rodriguez-Frias F, Jardi R, Tabernero D, Homs M, Ruiz G, Quer J, Esteban R, Buti M. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. J Hepatol 2010; 52: 658-664 [PMID: 20346531 DOI: 10.1016/j.jhep.2009.10.036]
49. Hadziyannis SJ. Hepatitis delta: an overview. In: Rizzetto M, Purcell RH, Gerin JL, and Verme G, editors. Viral Hepatitis and Liver Disease. Turin: Edizioni Minerva Medica, 1997: 283-289.
50. Pugnale P, Pazienza V, Guilloux K, Negro F. Hepatitis delta virus inhibits alpha interferon signaling. Hepatology 2009; 49: 398-406 [PMID: 19085955 DOI: 10.1002/hep.22654]
51. Magrin S, Craxì A, Carini C, Colombo P, di Blasi F, Spinelli G, Fratazzi C, Messina MC, Antonelli G, Ausiello C. Interleukin- 2, interleukin-2 receptor and gamma-interferon synthesis by peripheral blood mononuclear cells in chronic hepatitis delta virus infection. J Hepatol 1989; 8: 358-366 [PMID: 2499617 DOI: 10.1016/0168-8278(89)90035-4]
52. Nisini R, Paroli M, Accapezzato D, Bonino F, Rosina F, Santantonio T, Sallusto F, Amoroso A, Houghton M, Barnaba V. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol 1997; 71: 2241-2251 [PMID: 9032359]
53. Franco A, Barnaba V, Natali P, Balsano C, Musca A, Balsano F. Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology 1988; 8: 449-454 [PMID: 2453428 DOI: 10.1002/hep.1840080302]
54. Williams V, Brichler S, Khan E, Chami M, Dény P, Kremsdorf D, Gordien E. Large hepatitis delta antigen activates STAT-3 and NF-?B via oxidative stress. J Viral Hepat 2012; 19: 744-753 [PMID: 22967106 DOI: 10.1111/ j.1365-2893.2012.01597.x]
55. Huang IC, Chien CY, Huang CR, Lo SJ. Induction of hepatitis D virus large antigen translocation to the cytoplasm by hepatitis B virus surface antigens correlates with endoplasmic reticulum stress and NF-kappaB activation. J Gen Virol 2006; 87: 1715-1723 [PMID: 16690938 DOI: 10.1099/ vir.0.81718-0]
56. Liao FT, Lee YJ, Ko JL, Tsai CC, Tseng CJ, Sheu GT. Hepatitis delta virus epigenetically enhances clusterin expression via histone acetylation in human hepatocellular carcinoma cells. J Gen Virol 2009; 90: 1124-1134 [PMID: 19264665 DOI: 10.1099/vir.0.007211-0]
57. Löseke S, Grage-Griebenow E, Heine H, Wagner A, Akira S, Bauer S, Bufe A. In vitro-generated viral double-stranded RNA in contrast to polyinosinic: polycytidylic acid induces interferon-alpha in human plasmacytoid dendritic cells. Scand J Immunol 2006; 63: 264-274 [PMID: 16623926 DOI: 10.1111/j.1365-3083.2006.01736.x]
58. Larner A, Reich NC. Interferon signal transduction. Biotherapy 1996; 8: 175-181 [PMID: 8813329 DOI: 10.1007/ BF01877202]
59. Katashiba Y, Miyamoto R, Hyo A, Shimamoto K, Murakami N, Ogata M, Amakawa R, Inaba M, Nomura S, Fukuhara S, Ito T. Interferon-a and interleukin-12 are induced, respectively, by double-stranded DNA and singlestranded RNA in human myeloid dendritic cells. Immunology 2011; 132: 165-173 [PMID: 20875078 DOI: 10.1111/ j.1365-2567.2010.03350.x]
60. Hartwig D, Schütte C, Warnecke J, Dorn I, Hennig H, Kirchner H, Schlenke P. The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferonalpha- stimulated host cells. J Viral Hepat 2006; 13: 150-157 [PMID: 16475990]
61. Babiker ZO, Hogan C, Ustianowski A, Wilkins E. Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection. J Med Microbiol 2012; 61: 1780-1783 [PMID: 22956751 DOI: 10.1099/jmm.0.046649-0]
62. Kuhla A, Eipel C, Abshagen K, Siebert N, Menger MD, Vollmar B. Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced inflammatory liver injury. Am J Physiol Gastrointest Liver Physiol 2009; 296: G1069-G1076 [PMID: 19264954 DOI: 10.1152/ajpgi.90689.2008]
63. Grabowski J, Yurdaydìn C, Zachou K, Buggisch P, Hofmann WP, Jaroszewicz J, Schlaphoff V, Manns MP, Cornberg M, Wedemeyer H. Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment. Liver Int 2011; 31: 1395-1405 [PMID: 21762356 DOI: 10.1111/j.1478-3231.2011.02593.x]
64. Xia YP, Chang MF, Wei D, Govindarajan S, Lai MM. Heterogeneity of hepatitis delta antigen. Virology 1990; 178: 331-336 [PMID: 2389557 DOI: 10.1016/0042-6822(90)90415-N]
65. Imazeki F, Omata M, Ohto M. Heterogeneity and evolution rates of delta virus RNA sequences. J Virol 1990; 64: 5594-5599 [PMID: 2214027]
66. Tang JR, Hantz O, Vitvitski L, Lamelin JP, Parana R, Cova L, Lesbordes JL, Trépo C. Discovery of a novel point mutation changing the HDAg expression of a hepatitis delta virus isolate from Central African Republic. J Gen Virol 1993; 74 ( Pt 9): 1827-1835 [PMID: 8376962 DOI: 10.1099/0022-1317-74-9-1827]
67. Wu JC, Choo KB, Chen CM, Chen TZ, Huo TI, Lee SD. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet 1995; 346: 939-941 [PMID: 7564729 DOI: 10.1016/ S0140-6736(95)91558-3]
68. Kiesslich D, Crispim MA, Santos C, Ferreira Fde L, Fraiji NA, Komninakis SV, Diaz RS. Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus. J Infect Dis 2009; 199: 1608-1611 [PMID: 19388852 DOI: 10.1086/598955]
69. Smedile A, Farci P, Verme G, Caredda F, Cargnel A, Caporaso N, Dentico P, Trepo C, Opolon P, Gimson A, Vergani D, Williams R, Rizzetto M. Influence of delta infection on severity of hepatitis B. Lancet 1982; 2: 945-947 [PMID: 6127458 DOI: 10.1016/S0140-6736(82)90156-8]
70. Choi SH, Jeong SH, Hwang SB. Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis. Gastroenterology 2007; 132: 343-357 [PMID: 17241884 DOI: 10.1053/j.gastro.2006.10.038]
71. Shih HH, Sheen IJ, Su CW, Peng WL, Lin LH, Wu JC. Hepatitis D virus isolates with low replication and epithelialmesenchymal transition-inducing activity are associated with disease remission. J Virol 2012; 86: 9044-9054 [PMID: 22674995 DOI: 10.1128/JVI.00130-12]
72. Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J 1999; 18: 2449-2458 [PMID: 10228159 DOI: 10.1093/ emboj/18.9.2449]
73. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: downregulation of COX-2 and iNOS through suppression of NFkappa B activation. Mutat Res 2001; 480-481: 243-268 [PMID: 11506818]
74. Abbas Z, Qureshi M, Hamid S, Jafri W. Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection. Saudi J Gastroenterol 2012; 18: 18-22 [PMID: 22249087 DOI: 10.4103/1319-3767.91731]
75. Balantinou E, Trougakos IP, Chondrogianni N, Margaritis LH, Gonos ES. Transcriptional and posttranslational regulation of clusterin by the two main cellular proteolytic pathways. Free Radic Biol Med 2009; 46: 1267-1274 [PMID: 19353783 DOI: 10.1016/j.freeradbiomed.2009.01.025]
76. Hamamori Y, Sartorelli V, Ogryzko V, Puri PL, Wu HY, Wang JY, Nakatani Y, Kedes L. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 1999; 96: 405-413 [PMID: 10025406 DOI: 10.1016/S0092-8674(00)80553-X]
77. Valls E, de la Cruz X, Martánez-BalbÁs MA. The SV40 T antigen modulates CBP histone acetyltransferase activity. Nucleic Acids Res 2003; 31: 3114-3122 [PMID: 12799439 DOI: 10.1093/nar/gkg418]
78. Su CW, Huang YH, Huo TI, Shih HH, Sheen IJ, Chen SW, Lee PC, Lee SD, Wu JC. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology 2006; 130: 1625-1635 [PMID: 16697726 DOI: 10.1053/j.gastro.2006.01.035]
79. Nakano T, Shapiro CN, Hadler SC, Casey JL, Mizokami M, Orito E, Robertson BH. Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. J Gen Virol 2001; 82: 2183-2189 [PMID: 11514728]